Drug intelligence / Profile preview

Bio-Curcumin

Development stage
Unknown
Lead developer
DolCas Biotech
Modality
Small Molecules
Administration
Oral
01

Overview

Bio-Curcumin is a branded **dietary supplement ingredient/formulation** based on curcumin from *Curcuma longa* and positioned as a high-bioavailability turmeric extract rather than as an approved pharmaceutical drug. Commercial descriptions indicate it is a proprietary curcumin formulation standardized around curcuminoids and combined with turmeric essential oils and, in some marketed versions, phospholipid-based absorption technology to improve oral bioavailability relative to conventional curcumin. Its intended use is wellness support, especially for inflammation, joint health, antioxidant support, and general nutraceutical applications. Mechanistically, curcumin is a pleiotropic small-molecule polyphenol with broad reported effects on inflammatory and oxidative-stress signaling pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells and cyclooxygenase-related pathways, but Bio-Curcumin itself is not an approved drug with a single validated regulatory mechanism of action.

Brand names
Bio-Curcumin
Other names
bioavailable curcuminturmeric extract
02

Targets

NFKB1 (NF-κB1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on Bio-Curcumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Curcumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call